ADMA Biologics, Inc. (ADMA)
9.545
-0.30
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Market Cap : 2.151B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.217B |
| August 20, 2026 | 2.199B |
| August 19, 2026 | 2.265B |
| August 18, 2026 | 2.150B |
| August 17, 2026 | 2.105B |
| August 14, 2026 | 2.134B |
| August 13, 2026 | 2.121B |
| August 12, 2026 | 2.204B |
| August 11, 2026 | 2.232B |
| August 10, 2026 | 2.197B |
| August 07, 2026 | 2.231B |
| August 06, 2026 | 2.267B |
| August 05, 2026 | 2.087B |
| August 04, 2026 | 2.008B |
| August 03, 2026 | 1.970B |
| July 31, 2026 | 1.965B |
| July 30, 2026 | 2.014B |
| July 29, 2026 | 2.023B |
| July 28, 2026 | 2.042B |
| July 27, 2026 | 1.970B |
| July 24, 2026 | 1.921B |
| July 23, 2026 | 1.944B |
| July 22, 2026 | 1.947B |
| July 21, 2026 | 1.995B |
| July 20, 2026 | 2.033B |
| Date | Value |
|---|---|
| July 17, 2026 | 2.023B |
| July 16, 2026 | 2.046B |
| July 15, 2026 | 2.016B |
| July 14, 2026 | 2.060B |
| July 13, 2026 | 2.084B |
| July 10, 2026 | 2.109B |
| July 09, 2026 | 2.153B |
| July 08, 2026 | 2.128B |
| July 07, 2026 | 2.139B |
| July 06, 2026 | 2.128B |
| July 02, 2026 | 2.079B |
| July 01, 2026 | 2.000B |
| June 30, 2026 | 1.944B |
| June 29, 2026 | 1.944B |
| June 26, 2026 | 2.033B |
| June 25, 2026 | 2.026B |
| June 24, 2026 | 2.021B |
| June 23, 2026 | 2.019B |
| June 22, 2026 | 1.991B |
| June 18, 2026 | 1.930B |
| June 17, 2026 | 1.956B |
| June 16, 2026 | 1.993B |
| June 15, 2026 | 1.974B |
| June 12, 2026 | 1.907B |
| June 11, 2026 | 1.933B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Erasca, Inc. | 5.504B |
| Krystal Biotech, Inc. | 10.12B |
| Vericel Corp. | 2.167B |
| Emergent BioSolutions, Inc. | 265.22M |
| Exelixis, Inc. | 13.58B |
Market Cap Related Metrics
| PE Ratio | 13.55 |
| PS Ratio | 4.466 |
| Price to Book Value | 5.269 |
| Price to Free Cash Flow | 19.69 |
| Price | 9.545 |
| Earnings Yield | 7.38% |
| Operating PE Ratio | 10.57 |
| Normalized PE Ratio | 13.43 |